Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. MNTA, a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentations at two upcoming investor conferences.

Credit Suisse 2013 Healthcare Conference

Wednesday, November 13 at 11:30 a.m. MST (1:30 p.m. EST) in Scottsdale, AZ

Goldman Sachs US Emerging SMID Cap Growth Conference

Thursday, November 14 at 1:20 p.m. EST in New York, NY

The audio webcast of the presentations will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentations will be posted on the Momenta website approximately one hour after each event and will be available for two weeks following each presentation.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel products.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.